A panel of experienced drug, device, and biotechnology counsel will discuss a number of important rulings made in drug, device and biotechnology cases in the past year. This program will address how such holdings could impact the prosecution of your drug and device cases going forward. Areas of Webinar focus will include preemption, personal jurisdiction, and the learned intermediary doctrine. The panel will discuss possible best practices in light of the recent rulings.
Moderator -- Katherine Lett (Norton Rose Fulbright US LLP); other speaker – Travis Swearingen (Butler Snow LLP)
For more details on this webinar, visit the event page here.